travail 发表于 2025-3-28 16:11:20
https://doi.org/10.1007/978-3-030-25253-3arr Virus (EBV, also known as human herpesvirus-4). While PCNSL in immune-competent patients and AR-PCNSL have pathologic and clinical overlap, AR-PCNSL is distinguished by its strong association with immunosuppression and viral etiology.committed 发表于 2025-3-28 18:45:42
Book 2014 young men was one of the first signs of this new disease. It was soon recognized that AIDS was caused by infection with a novel virus (HIV) and that AIDS patients are prone to develop a number of “AIDS-defining” cancers: Kaposi sarcoma, lymphoma, and cervical cancer. The development of effective co易达到 发表于 2025-3-29 01:53:51
Carsten Lenfers,Nils Beck,Marc Bauering disease. EBV is the cause of or contributing factor to the development of a number of HIV-associated cancers, including nearly all cases of central nervous system lymphoma and plasmablastic lymphoma, as well as a high percentage of other non-Hodgkin lymphomas and Hodgkin lymphomas.nonplus 发表于 2025-3-29 04:44:39
http://reply.papertrans.cn/23/2213/221287/221287_44.png宿醉 发表于 2025-3-29 10:11:24
Ana Carolina Botelho e Souza,Rolf Radespielusion in the pleural, pericardial, or peritoneal cavity characterized by the presence of KSHV-infected cells with characteristic morphology and phenotype. The clinical course of PEL is generally aggressive, with a mean survival of less than 1 year, despite chemotherapy.反抗者 发表于 2025-3-29 14:40:37
http://reply.papertrans.cn/23/2213/221287/221287_46.png没花的是打扰 发表于 2025-3-29 18:40:55
Burkitt and Burkitt-Like Lymphomaly aggressive, being the most rapidly growing cancer known and doubling every 24 h, it is also very responsive to modern chemotherapy. With currently available regimens, 90 % of patients can expect to be cured when properly treated.gonioscopy 发表于 2025-3-29 22:58:43
http://reply.papertrans.cn/23/2213/221287/221287_48.pngVAN 发表于 2025-3-30 00:10:08
http://reply.papertrans.cn/23/2213/221287/221287_49.pngJADED 发表于 2025-3-30 07:18:22
HIV Cancers in Resource-Limited Regionsr is diagnosed in about 30 % of PLHA in developed countries. Cancers in PLHA are historically categorized as “AIDS-defining” cancer (ADC) or “non-AIDS-defining” cancers (NADC). ADCs include Kaposi sarcoma (KS), aggressive non-Hodgkin lymphoma (NHL), including Burkitt lymphoma (BL), and invasive cerv